The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 06, 2024
Filed:
Sep. 29, 2021
Applicant:
Immatics Biotechnologies Gmbh, Tuebingen, DE;
Inventors:
Jens Hukelmann, Tuebingen, DE;
Heiko Schuster, Tuebingen, DE;
Lena Wullkopf, Tuebingen, DE;
Christoph Schraeder, Tuebingen, DE;
Jens Fritsche, Tuebingen, DE;
Daniel Johannes Kowalewski, Tuebingen, DE;
Michael Roemer, Tuebingen, DE;
Oliver Schoor, Tuebingen, DE;
Assignee:
IMMATICS BIOTECHNOLOGIES GMBH, Tuebingen, DE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/725 (2006.01); A61K 35/17 (2015.01); C07K 14/74 (2006.01); C07K 16/28 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/7051 (2013.01); A61K 35/17 (2013.01); C07K 14/70539 (2013.01); C07K 16/2833 (2013.01); A61K 38/00 (2013.01); C07K 2319/30 (2013.01);
Abstract
The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 113, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.